{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:14:18Z","timestamp":1787314458413,"version":"build-2736575974"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Pujiang Talents Program","award":["23PJD011"],"award-info":[{"award-number":["23PJD011"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3402700"],"award-info":[{"award-number":["2023YFC3402700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012242","name":"Program of Shanghai Subject Chief Scientist","doi-asserted-by":"publisher","award":["2022XD005"],"award-info":[{"award-number":["2022XD005"]}],"id":[{"id":"10.13039\/501100012242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00900-8","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:07:32Z","timestamp":1769738852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multi-omics profiling reveals intrathymic triggers and novel biomarkers in thymoma-associated myasthenia gravis"],"prefix":"10.1186","volume":"14","author":[{"given":"Yongqiang","family":"Ao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhe","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junkan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"900_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-immunol-101220-014126","volume":"40","author":"PJ Fink","year":"2022","unstructured":"Fink PJ, Exposing T. Cell secrets inside and outside the thymus. Annu Rev Immunol. 2022;40:1\u201314. https:\/\/doi.org\/10.1146\/annurev-immunol-101220-014126.","journal-title":"Annu Rev Immunol"},{"key":"900_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-immunol-051116-052320","volume":"35","author":"J Abramson","year":"2017","unstructured":"Abramson J, Anderson G. Thymic epithelial cells. Annu Rev Immunol. 2017;35:85\u2013118. https:\/\/doi.org\/10.1146\/annurev-immunol-051116-052320.","journal-title":"Annu Rev Immunol"},{"key":"900_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1146\/annurev-immunol-042718-041319","volume":"37","author":"A Cumano","year":"2019","unstructured":"Cumano A, Berthault C, Ramond C, Petit M, Golub R, Bandeira A, et al. New molecular insights into immune cell development. Annu Rev Immunol. 2019;37:497\u2013519. https:\/\/doi.org\/10.1146\/annurev-immunol-042718-041319.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"900_CR4","doi-asserted-by":"publisher","first-page":"188730","DOI":"10.1016\/j.bbcan.2022.188730","volume":"1877","author":"YQ Ao","year":"2022","unstructured":"Ao YQ, Jiang JH, Gao J, Wang HK, Ding JY. Recent thymic emigrants as the Bridge between thymoma and autoimmune diseases. Biochim Et Biophys Acta Reviews Cancer. 2022;1877(3):188730. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188730.","journal-title":"Biochim Et Biophys Acta Reviews Cancer"},{"issue":"7","key":"900_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11864-019-0661-2","volume":"20","author":"EA Lippner","year":"2019","unstructured":"Lippner EA, Lewis DB, Robinson WH, Katsumoto TR. Paraneoplastic and Therapy-Related immune complications in thymic malignancies. Curr Treat Options Oncol. 2019;20(7):62. https:\/\/doi.org\/10.1007\/s11864-019-0661-2.","journal-title":"Curr Treat Options Oncol"},{"issue":"3","key":"900_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/cmi.2010.74","volume":"8","author":"S Shelly","year":"2011","unstructured":"Shelly S, Agmon-Levin N, Altman A, Shoenfeld Y. Thymoma and autoimmunity. Cell Mol Immunol. 2011;8(3):199\u2013202. https:\/\/doi.org\/10.1038\/cmi.2010.74.","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"900_CR7","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14(10):1023\u201336. https:\/\/doi.org\/10.1016\/s1474-4422(15)00145-3.","journal-title":"Lancet Neurol"},{"issue":"10","key":"900_CR8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/jto.0000000000000654","volume":"10","author":"A Marx","year":"2015","unstructured":"Marx A, Chan JK, Coindre JM, Detterbeck F, Girard N, Harris NL, et al. The 2015 world health organization classification of tumors of the thymus: continuity and changes. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2015;10(10):1383\u201395. https:\/\/doi.org\/10.1097\/jto.0000000000000654.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"11","key":"900_CR9","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1002\/ijc.25583","volume":"128","author":"SM Gadalla","year":"2011","unstructured":"Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Bj\u00f6rkholm M, Landgren O, et al. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer. 2011;128(11):2688\u201394. https:\/\/doi.org\/10.1002\/ijc.25583.","journal-title":"Int J Cancer"},{"issue":"7","key":"900_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/jamaneurol.2016.0603","volume":"73","author":"A Zekeridou","year":"2016","unstructured":"Zekeridou A, McKeon A, Lennon VA. Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma. JAMA Neurol. 2016;73(7):853\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0603.","journal-title":"JAMA Neurol"},{"issue":"2","key":"900_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):176\u201388. https:\/\/doi.org\/10.1016\/s1474-4422(21)00297-0.","journal-title":"Lancet Neurol"},{"issue":"3","key":"900_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3988\/jcn.2012.8.3.161","volume":"8","author":"ZF Mao","year":"2012","unstructured":"Mao ZF, Mo XA, Qin C, Lai YR, Hackett ML. Incidence of thymoma in myasthenia gravis: a systematic review. J Clin Neurol (Seoul Korea). 2012;8(3):161\u20139. https:\/\/doi.org\/10.3988\/jcn.2012.8.3.161.","journal-title":"J Clin Neurol (Seoul Korea)"},{"key":"900_CR13","doi-asserted-by":"publisher","unstructured":"Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Investig. 2024;134(12). https:\/\/doi.org\/10.1172\/jci179742.","DOI":"10.1172\/jci179742"},{"issue":"2","key":"900_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41582-023-00916-w","volume":"20","author":"R Iorio","year":"2024","unstructured":"Iorio R. Myasthenia gravis: the changing treatment landscape in the era of molecular therapies. Nat Reviews Neurol. 2024;20(2):84\u201398. https:\/\/doi.org\/10.1038\/s41582-023-00916-w.","journal-title":"Nat Reviews Neurol"},{"key":"900_CR15","doi-asserted-by":"publisher","first-page":"578129","DOI":"10.1016\/j.jneuroim.2023.578129","volume":"381","author":"M Cebi","year":"2023","unstructured":"Cebi M, Cakar A, Erdogdu E, Durmus-Tekce H, Yegen G, Ozkan B, et al. Thymoma patients with or without myasthenia Gravis have increased Th17 cells, IL-17 production and ICOS expression. J Neuroimmunol. 2023;381:578129. https:\/\/doi.org\/10.1016\/j.jneuroim.2023.578129.","journal-title":"J Neuroimmunol"},{"issue":"26","key":"900_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;375(26):2570\u201381. https:\/\/doi.org\/10.1056\/NEJMra1602678.","journal-title":"N Engl J Med"},{"issue":"38","key":"900_CR17","doi-asserted-by":"publisher","first-page":"E1141","DOI":"10.1503\/cmaj.180656","volume":"190","author":"PR Bourque","year":"2018","unstructured":"Bourque PR, Breiner A. Myasthenia Gravis. CMAJ: Can Med Association J = J De l\u2019Association Medicale Canadienne. 2018;190(38):E1141. https:\/\/doi.org\/10.1503\/cmaj.180656.","journal-title":"CMAJ: Can Med Association J = J De l\u2019Association Medicale Canadienne"},{"issue":"3","key":"900_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00415-025-12922-7","volume":"272","author":"SNM Binks","year":"2025","unstructured":"Binks SNM, Morse IM, Ashraghi M, Vincent A, Waters P, Leite MI. Myasthenia Gravis in 2025: five new things and four hopes for the future. J Neurol. 2025;272(3):226. https:\/\/doi.org\/10.1007\/s00415-025-12922-7.","journal-title":"J Neurol"},{"issue":"12","key":"900_CR19","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/s1474-4422(17)30369-1","volume":"16","author":"JF Howard Jr","year":"2017","unstructured":"Howard JF Jr., Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, et al. Safety and efficacy of Eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia Gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16(12):976\u201386. https:\/\/doi.org\/10.1016\/s1474-4422(17)30369-1.","journal-title":"Lancet Neurol"},{"issue":"7","key":"900_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/s1474-4422(21)00159-9","volume":"20","author":"JF Howard Jr","year":"2021","unstructured":"Howard JF Jr., Bril V, Vu T, Karam C, Peric S, Margania T, et al. Safety, efficacy, and tolerability of Efgartigimod in patients with generalised myasthenia Gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial. Lancet Neurol. 2021;20(7):526\u201336. https:\/\/doi.org\/10.1016\/s1474-4422(21)00159-9.","journal-title":"Lancet Neurol"},{"key":"900_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.04.014","author":"S Wang","year":"2025","unstructured":"Wang S, Zhu M, Dong J, Zhang Y, Luo S, Jiang J, et al. Perioperative safety and efficacy of Efgartigimod for thymoma associated myasthenia gravis: A Prospective, Multicenter, phase II clinical trial. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2025. https:\/\/doi.org\/10.1016\/j.jtho.2025.04.014.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"10 Suppl 4","key":"900_CR22","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.1097\/JTO.0b013e3181f1f63f","volume":"5","author":"A Marx","year":"2010","unstructured":"Marx A, Hohenberger P, Hoffmann H, Pfannschmidt J, Schnabel P, Hofmann HS, et al. The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2010;5(10 Suppl 4):S266\u201372. https:\/\/doi.org\/10.1097\/JTO.0b013e3181f1f63f.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"key":"900_CR23","doi-asserted-by":"publisher","unstructured":"Iacomino N, Scandiffio L, Conforti F, Salvi E, Tarasco MC, Bortone F, et al. Muscle and Muscle-like autoantigen expression in myasthenia Gravis thymus: possible molecular hint for autosensitization. Biomedicines. 2023;11(3). https:\/\/doi.org\/10.3390\/biomedicines11030732.","DOI":"10.3390\/biomedicines11030732"},{"issue":"1","key":"900_CR24","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41467-022-31951-8","volume":"13","author":"Y Yasumizu","year":"2022","unstructured":"Yasumizu Y, Ohkura N, Murata H, Kinoshita M, Funaki S, Nojima S, et al. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. Nat Commun. 2022;13(1):4230. https:\/\/doi.org\/10.1038\/s41467-022-31951-8.","journal-title":"Nat Commun"},{"issue":"4","key":"900_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41422-024-00929-0","volume":"34","author":"Y Lin","year":"2024","unstructured":"Lin Y, Wan Z, Liu B, Yao J, Li T, Yang F, et al. B cell-reactive triad of B cells, follicular helper and regulatory T cells at homeostasis. Cell Res. 2024;34(4):295\u2013308. https:\/\/doi.org\/10.1038\/s41422-024-00929-0.","journal-title":"Cell Res"},{"issue":"9","key":"900_CR26","doi-asserted-by":"publisher","first-page":"114677","DOI":"10.1016\/j.celrep.2024.114677","volume":"43","author":"Y Yasumizu","year":"2024","unstructured":"Yasumizu Y, Kinoshita M, Zhang MJ, Motooka D, Suzuki K, Nojima S, et al. Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis-associated thymoma. Cell Rep. 2024;43(9):114677. https:\/\/doi.org\/10.1016\/j.celrep.2024.114677.","journal-title":"Cell Rep"},{"issue":"9","key":"900_CR27","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s41379-022-01070-2","volume":"35","author":"J Sarkkinen","year":"2022","unstructured":"Sarkkinen J, Dunkel J, Tuulasvaara A, Huuskonen A, Atula S, Kek\u00e4l\u00e4inen E, et al. Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia Gravis after thymectomy. Mod Pathology: Official J United States Can Acad Pathol Inc. 2022;35(9):1168\u201374. https:\/\/doi.org\/10.1038\/s41379-022-01070-2.","journal-title":"Mod Pathology: Official J United States Can Acad Pathol Inc"},{"issue":"20","key":"900_CR28","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1056\/NEJMc1611704","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Cutter GR. Randomized trial of thymectomy in myasthenia Gravis. N Engl J Med. 2016;375(20):2006\u20137. https:\/\/doi.org\/10.1056\/NEJMc1611704.","journal-title":"N Engl J Med"},{"issue":"6","key":"900_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB, Minisman G, Kuo HC, Marx A, et al. Randomized trial of thymectomy in myasthenia Gravis. N Engl J Med. 2016;375(6):511\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1602489.","journal-title":"N Engl J Med"},{"issue":"6","key":"900_CR30","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.athoracsur.2020.12.010","volume":"112","author":"V Aprile","year":"2021","unstructured":"Aprile V, Korasidis S, Bacchin D, Petralli G, Petrini I, Ricciardi R, et al. Thymectomy in myasthenic patients with thymoma: killing two birds with one stone. Ann Thorac Surg. 2021;112(6):1782\u20139. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.12.010.","journal-title":"Ann Thorac Surg"},{"key":"900_CR31","doi-asserted-by":"publisher","unstructured":"Ao YQ, Gao J, Jin C, Wang S, Zhang LC, Deng J, et al. ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination Inhibition of STAT3. J Immunother Cancer. 2023;11(12). https:\/\/doi.org\/10.1136\/jitc-2023-007766.","DOI":"10.1136\/jitc-2023-007766"},{"issue":"1","key":"900_CR32","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1038\/s41467-022-33170-7","volume":"13","author":"Z Xin","year":"2022","unstructured":"Xin Z, Lin M, Hao Z, Chen D, Chen Y, Chen X, et al. The immune landscape of human thymic epithelial tumors. Nat Commun. 2022;13(1):5463. https:\/\/doi.org\/10.1038\/s41467-022-33170-7.","journal-title":"Nat Commun"},{"key":"900_CR33","doi-asserted-by":"publisher","unstructured":"Park JE, Botting RA, Dom\u00ednguez Conde C, Popescu DM, Lavaert M, Kunz DJ, et al. A cell atlas of human thymic development defines T cell repertoire formation. Sci (New York NY). 2020;367(6480). https:\/\/doi.org\/10.1126\/science.aay3224.","DOI":"10.1126\/science.aay3224"},{"issue":"1","key":"900_CR34","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1038\/s41467-020-18697-x","volume":"11","author":"S Gao","year":"2020","unstructured":"Gao S, Jiang J, Jin C, Gao J, Xiong D, Yang P, et al. Interleukin-8 as a candidate for thymoma identification and recurrence surveillance. Nat Commun. 2020;11(1):4881. https:\/\/doi.org\/10.1038\/s41467-020-18697-x.","journal-title":"Nat Commun"},{"issue":"10","key":"900_CR35","doi-asserted-by":"publisher","first-page":"103875","DOI":"10.1016\/j.autrev.2025.103875","volume":"24","author":"M Man\u00e9-Damas","year":"2025","unstructured":"Man\u00e9-Damas M, Sch\u00f6ttler AK, Marcuse F, Molenaar PC, Mohile T, Hoeijmakers JGJ, et al. Myasthenia Gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells. Autoimmun Rev. 2025;24(10):103875. https:\/\/doi.org\/10.1016\/j.autrev.2025.103875.","journal-title":"Autoimmun Rev"},{"key":"900_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC, Follicular Helper T, Cells. Annu Rev Immunol. 2016;34:335\u201368. https:\/\/doi.org\/10.1146\/annurev-immunol-041015-055605.","journal-title":"Annu Rev Immunol"},{"issue":"35","key":"900_CR37","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1038\/onc.2008.120","volume":"27","author":"JM Hernandez","year":"2008","unstructured":"Hernandez JM, Floyd DH, Weilbaecher KN, Green PL, Boris-Lawrie K. Multiple facets of JunD gene expression are atypical among AP-1 family members. Oncogene. 2008;27(35):4757\u201367. https:\/\/doi.org\/10.1038\/onc.2008.120.","journal-title":"Oncogene"},{"issue":"10","key":"900_CR38","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1038\/leu.2017.74","volume":"31","author":"M Terol","year":"2017","unstructured":"Terol M, Gazon H, Lemasson I, Duc-Dodon M, Barbeau B, C\u00e9saire R, et al. HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by Inhibition of ribosomal protein S25 expression. Leukemia. 2017;31(10):2235\u201343. https:\/\/doi.org\/10.1038\/leu.2017.74.","journal-title":"Leukemia"},{"issue":"6","key":"900_CR39","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s10565-023-09822-9","volume":"39","author":"Y Chang","year":"2023","unstructured":"Chang Y, Chen L, Tang J, Chen G, Ji J, Xu M. USP7-mediated JUND suppresses RCAN2 transcription and elevates NFATC1 to enhance stem cell property in colorectal cancer. Cell Biol Toxicol. 2023;39(6):3121\u201340. https:\/\/doi.org\/10.1007\/s10565-023-09822-9.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"900_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0092-8674(00)80967-8","volume":"96","author":"SK Agarwal","year":"1999","unstructured":"Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, et al. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell. 1999;96(1):143\u201352. https:\/\/doi.org\/10.1016\/s0092-8674(00)80967-8.","journal-title":"Cell"},{"issue":"7386","key":"900_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature10806","volume":"482","author":"J Huang","year":"2012","unstructured":"Huang J, Gurung B, Wan B, Matkar S, Veniaminova NA, Wan K, et al. The same pocket in Menin binds both MLL and JUND but has opposite effects on transcription. Nature. 2012;482(7386):542\u20136. https:\/\/doi.org\/10.1038\/nature10806.","journal-title":"Nature"},{"issue":"4","key":"900_CR42","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/s1097-2765","volume":"13","author":"SH Yang","year":"2004","unstructured":"Yang SH, Sharrocks AD. SUMO promotes HDAC-mediated transcriptional repression. Mol Cell. 2004;13(4):611\u20137. https:\/\/doi.org\/10.1016\/s1097-2765. (04)00060\u2009\u2013\u20097.","journal-title":"Mol Cell"},{"issue":"19","key":"900_CR43","first-page":"6135","volume":"63","author":"H Kim","year":"2003","unstructured":"Kim H, Lee JE, Cho EJ, Liu JO, Youn HD. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res. 2003;63(19):6135\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"900_CR44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ng.137","volume":"40","author":"J Behmoaras","year":"2008","unstructured":"Behmoaras J, Bhangal G, Smith J, McDonald K, Mutch B, Lai PC, et al. Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility. Nat Genet. 2008;40(5):553\u20139. https:\/\/doi.org\/10.1038\/ng.137.","journal-title":"Nat Genet"},{"key":"900_CR45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2014.00058","volume":"5","author":"B Carow","year":"2014","unstructured":"Carow B, Rottenberg ME. SOCS3, a major regulator of infection and inflammation. Front Immunol. 2014;5:58. https:\/\/doi.org\/10.3389\/fimmu.2014.00058.","journal-title":"Front Immunol"},{"issue":"6","key":"900_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7(6):454\u201365. https:\/\/doi.org\/10.1038\/nri2093.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"900_CR47","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/nm896","volume":"9","author":"Y Seki","year":"2003","unstructured":"Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, et al. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med. 2003;9(8):1047\u201354. https:\/\/doi.org\/10.1038\/nm896.","journal-title":"Nat Med"},{"issue":"6","key":"900_CR48","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/intimm\/dxp037","volume":"21","author":"S Kagami","year":"2009","unstructured":"Kagami S, Owada T, Kanari H, Saito Y, Suto A, Ikeda K, et al. Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3\u2009+\u2009regulatory T cells. Int Immunol. 2009;21(6):679\u201389. https:\/\/doi.org\/10.1093\/intimm\/dxp037.","journal-title":"Int Immunol"},{"issue":"2","key":"900_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1182\/blood-2009-12-259598","volume":"116","author":"GR Hill","year":"2010","unstructured":"Hill GR, Kuns RD, Raffelt NC, Don AL, Olver SD, Markey KA, et al. SOCS3 regulates graft-versus-host disease. Blood. 2010;116(2):287\u201396. https:\/\/doi.org\/10.1182\/blood-2009-12-259598.","journal-title":"Blood"},{"issue":"3","key":"900_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12026-014-8612-2","volume":"61","author":"X Liu","year":"2015","unstructured":"Liu X, Ren S, Qu X, Ge C, Cheng K, Zhao RC. Mesenchymal stem cells inhibit Th17 cells differentiation via IFN-\u03b3-mediated SOCS3 activation. Immunol Res. 2015;61(3):219\u201329. https:\/\/doi.org\/10.1007\/s12026-014-8612-2.","journal-title":"Immunol Res"},{"issue":"8","key":"900_CR51","doi-asserted-by":"publisher","first-page":"112940","DOI":"10.1016\/j.celrep.2023.112940","volume":"42","author":"S Mise-Omata","year":"2023","unstructured":"Mise-Omata S, Ando M, Srirat T, Nakagawara K, Hayakawa T, Iizuka-Koga M, et al. SOCS3 deletion in effector T cells confers an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine. Cell Rep. 2023;42(8):112940. https:\/\/doi.org\/10.1016\/j.celrep.2023.112940.","journal-title":"Cell Rep"},{"key":"900_CR52","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3389\/fimmu.2020.00782","volume":"11","author":"F Truffault","year":"2020","unstructured":"Truffault F, Nazzal D, Verdier J, Gradolatto A, Fadel E, Roussin R, et al. Comparative analysis of thymic and blood Treg in myasthenia gravis: thymic epithelial cells contribute to thymic immunoregulatory defects. Front Immunol. 2020;11:782. https:\/\/doi.org\/10.3389\/fimmu.2020.00782.","journal-title":"Front Immunol"},{"issue":"3","key":"900_CR53","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.3390\/ijms16035434","volume":"16","author":"MP Zafra","year":"2015","unstructured":"Zafra MP, Ca\u00f1as JA, Mazzeo C, G\u00e1mez C, Sanz V, Fern\u00e1ndez-Nieto M, et al. SOCS3 Silencing attenuates eosinophil functions in asthma patients. Int J Mol Sci. 2015;16(3):5434\u201351. https:\/\/doi.org\/10.3390\/ijms16035434.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"900_CR54","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/eji.200737193","volume":"37","author":"BB Pillemer","year":"2007","unstructured":"Pillemer BB, Xu H, Oriss TB, Qi Z, Ray A. Deficient SOCS3 expression in CD4\u2009+\u2009CD25\u2009+\u2009FoxP3\u2009+\u2009regulatory T cells and SOCS3-mediated suppression of Treg function. Eur J Immunol. 2007;37(8):2082\u20139. https:\/\/doi.org\/10.1002\/eji.200737193.","journal-title":"Eur J Immunol"},{"key":"900_CR55","doi-asserted-by":"publisher","first-page":"103590","DOI":"10.1016\/j.redox.2025.103590","volume":"82","author":"H Satooka","year":"2025","unstructured":"Satooka H, Nakamura Y, Hirata T. ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development. Redox Biol. 2025;82:103590. https:\/\/doi.org\/10.1016\/j.redox.2025.103590.","journal-title":"Redox Biol"},{"issue":"6","key":"900_CR56","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-021-02299-y","volume":"141","author":"F Ingelfinger","year":"2021","unstructured":"Ingelfinger F, Krishnarajah S, Kramer M, Utz SG, Galli E, Lutz M, et al. Single-cell profiling of myasthenia Gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141(6):901\u201315. https:\/\/doi.org\/10.1007\/s00401-021-02299-y.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"900_CR57","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/eurheartj\/ehy903","volume":"40","author":"S Costantino","year":"2019","unstructured":"Costantino S, Akhmedov A, Melina G, Mohammed SA, Othman A, Ambrosini S, et al. Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy. Eur Heart J. 2019;40(12):997\u20131008. https:\/\/doi.org\/10.1093\/eurheartj\/ehy903.","journal-title":"Eur Heart J"},{"issue":"1","key":"900_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-024-01862-2","volume":"10","author":"Q Meng","year":"2024","unstructured":"Meng Q, Xie Y, Sun K, He L, Wu H, Zhang Q, et al. ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Cell Death Discovery. 2024;10(1):97. https:\/\/doi.org\/10.1038\/s41420-024-01862-2.","journal-title":"Cell Death Discovery"},{"issue":"4","key":"900_CR59","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/rheumatology\/keaa589","volume":"60","author":"J Aarts","year":"2021","unstructured":"Aarts J, Roeleveld DM, Helsen MM, Walgreen B, Vitters EL, Kolls J, et al. Systemic overexpression of interleukin-22 induces the negative immune-regulator SOCS3 and potently reduces experimental arthritis in mice. Rheumatology (Oxford). 2021;60(4):1974\u201383. https:\/\/doi.org\/10.1093\/rheumatology\/keaa589.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"900_CR60","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.it.2009.07.001","volume":"30","author":"BJ Baker","year":"2009","unstructured":"Baker BJ, Akhtar LN, Benveniste EN. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 2009;30(8):392\u2013400. https:\/\/doi.org\/10.1016\/j.it.2009.07.001.","journal-title":"Trends Immunol"},{"issue":"6","key":"900_CR61","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/sj.emboj.7600133","volume":"23","author":"A Meixner","year":"2004","unstructured":"Meixner A, Karreth F, Kenner L, Wagner EF. JunD regulates lymphocyte proliferation and T helper cell cytokine expression. EMBO J. 2004;23(6):1325\u201335. https:\/\/doi.org\/10.1038\/sj.emboj.7600133.","journal-title":"EMBO J"},{"key":"900_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmet.2019.05.009","volume":"26","author":"AL Good","year":"2019","unstructured":"Good AL, Haemmerle MW, Oguh AU, Doliba NM, Stoffers DA. Metabolic stress activates an ERK\/hnRNPK\/DDX3X pathway in pancreatic \u03b2 cells. Mol Metabolism. 2019;26:45\u201356. https:\/\/doi.org\/10.1016\/j.molmet.2019.05.009.","journal-title":"Mol Metabolism"},{"issue":"2","key":"900_CR63","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0039-6060(98)70257-0","volume":"123","author":"S Wang","year":"1998","unstructured":"Wang S, Evers BM. Cytokine-mediated differential induction of hepatic activator protein-1 genes. Surgery. 1998;123(2):191\u20138.","journal-title":"Surgery"},{"issue":"17","key":"900_CR64","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-016-2234-x","volume":"73","author":"R Mahony","year":"2016","unstructured":"Mahony R, Ahmed S, Diskin C, Stevenson NJ. SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci. 2016;73(17):3323\u201336. https:\/\/doi.org\/10.1007\/s00018-016-2234-x.","journal-title":"Cell Mol Life Sci"},{"issue":"7","key":"900_CR65","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/pros.22800","volume":"74","author":"F Mehraein-Ghomi","year":"2014","unstructured":"Mehraein-Ghomi F, Kegel SJ, Church DR, Schmidt JS, Reuter QR, Saphner EL, et al. Targeting androgen receptor and JunD interaction for prevention of prostate cancer progression. Prostate. 2014;74(7):792\u2013803. https:\/\/doi.org\/10.1002\/pros.22800.","journal-title":"Prostate"},{"issue":"6","key":"900_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/nri3667","volume":"14","author":"L Klein","year":"2014","unstructured":"Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of the T cell repertoire: what thymocytes see (and don\u2019t see). Nat Rev Immunol. 2014;14(6):377\u201391. https:\/\/doi.org\/10.1038\/nri3667.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"900_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00281-021-00842-3","volume":"43","author":"A Marx","year":"2021","unstructured":"Marx A, Yamada Y, Simon-Keller K, Schalke B, Willcox N, Str\u00f6bel P, et al. Thymus and autoimmunity. Semin Immunopathol. 2021;43(1):45\u201364. https:\/\/doi.org\/10.1007\/s00281-021-00842-3.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"900_CR68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood.v100.1.159","volume":"100","author":"P Str\u00f6bel","year":"2002","unstructured":"Str\u00f6bel P, Helmreich M, Menioudakis G, Lewin SR, R\u00fcdiger T, Bauer A, et al. Paraneoplastic myasthenia Gravis correlates with generation of mature Naive CD4(+) T cells in thymomas. Blood. 2002;100(1):159\u201366. https:\/\/doi.org\/10.1182\/blood.v100.1.159.","journal-title":"Blood"},{"issue":"8003","key":"900_CR69","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41586-024-07079-8","volume":"627","author":"AM Afzali","year":"2024","unstructured":"Afzali AM, Nirschl L, Sie C, Pfaller M, Ulianov O, Hassler T, et al. B cells orchestrate tolerance to the neuromyelitis Optica autoantigen AQP4. Nature. 2024;627(8003):407\u201315. https:\/\/doi.org\/10.1038\/s41586-024-07079-8.","journal-title":"Nature"},{"key":"900_CR70","doi-asserted-by":"publisher","first-page":"102612","DOI":"10.1016\/j.jaut.2021.102612","volume":"119","author":"M Khosravi-Maharlooei","year":"2021","unstructured":"Khosravi-Maharlooei M, Li H, Hoelzl M, Zhao G, Ruiz A, Misra A, et al. Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice. J Autoimmun. 2021;119:102612. https:\/\/doi.org\/10.1016\/j.jaut.2021.102612.","journal-title":"J Autoimmun"},{"issue":"8","key":"900_CR71","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s00415-004-0479-z","volume":"251","author":"XJ Chen","year":"2004","unstructured":"Chen XJ, Qiao J, Xiao BG, Lu CZ. The significance of Titin antibodies in myasthenia Gravis\u2013correlation with thymoma and severity of myasthenia Gravis. J Neurol. 2004;251(8):1006\u201311. https:\/\/doi.org\/10.1007\/s00415-004-0479-z.","journal-title":"J Neurol"},{"issue":"2","key":"900_CR72","doi-asserted-by":"publisher","first-page":"973","DOI":"10.21037\/jtd-23-94","volume":"16","author":"J Moura","year":"2024","unstructured":"Moura J, Sousa AP, Sam\u00f5es R, Carneiro P, Neves E, Silva AM, et al. Anti-titin antibodies in a cohort of myasthenia Gravis patients. J Thorac Disease. 2024;16(2):973\u20138. https:\/\/doi.org\/10.21037\/jtd-23-94.","journal-title":"J Thorac Disease"},{"issue":"6","key":"900_CR73","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00415-017-8514-z","volume":"264","author":"I Cordts","year":"2017","unstructured":"Cordts I, Bodart N, Hartmann K, Karagiorgou K, Tzartos JS, Mei L, et al. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia Gravis. J Neurol. 2017;264(6):1193\u2013203. https:\/\/doi.org\/10.1007\/s00415-017-8514-z.","journal-title":"J Neurol"},{"key":"900_CR74","doi-asserted-by":"publisher","first-page":"102337","DOI":"10.1016\/j.jaut.2019.102337","volume":"106","author":"CM Lefeuvre","year":"2020","unstructured":"Lefeuvre CM, Payet CA, Fayet OM, Maillard S, Truffault F, Bondet V, et al. Risk factors associated with myasthenia Gravis in thymoma patients: the potential role of thymic germinal centers. J Autoimmun. 2020;106:102337. https:\/\/doi.org\/10.1016\/j.jaut.2019.102337.","journal-title":"J Autoimmun"},{"key":"900_CR75","doi-asserted-by":"publisher","unstructured":"\u00c1lvarez-Velasco R, Dols-Icardo O, El Bounasri S, L\u00f3pez-Vilar\u00f3 L, Trujillo JC, Reyes-Leiva D, et al. Reduced number of thymoma CTLA4-Positive cells is associated with a higher probability of developing myasthenia Gravis. Neurology(R) Neuroimmunol Neuroinflammation. 2023;10(2). https:\/\/doi.org\/10.1212\/nxi.0000000000200085.","DOI":"10.1212\/nxi.0000000000200085"},{"issue":"1","key":"900_CR76","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s12016-016-8558-3","volume":"52","author":"F Truffault","year":"2017","unstructured":"Truffault F, de Montpreville V, Eymard B, Sharshar T, Le Panse R, Berrih-Aknin S. Thymic germinal centers and corticosteroids in myasthenia gravis: an immunopathological study in 1035 cases and a critical review. Clin Rev Allergy Immunol. 2017;52(1):108\u201324. https:\/\/doi.org\/10.1007\/s12016-016-8558-3.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"900_CR77","doi-asserted-by":"publisher","first-page":"2347379","DOI":"10.1080\/08916934.2024.2347379","volume":"57","author":"T Wang","year":"2024","unstructured":"Wang T, Wang B, Fan X, Cai Y, Li L, Fu S. Type B thymomas in patients with myasthenia Gravis display a distinctive pattern of \u03b1\u03b2 TCR and IL-7 receptor \u03b1 expression on CD4(+)CD8(+) thymocytes. Autoimmunity. 2024;57(1):2347379. https:\/\/doi.org\/10.1080\/08916934.2024.2347379.","journal-title":"Autoimmunity"},{"issue":"2","key":"900_CR78","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s10875-007-9147-2","volume":"28","author":"A Fattorossi","year":"2008","unstructured":"Fattorossi A, Battaglia A, Buzzonetti A, Minicuci G, Riso R, Peri L, et al. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy. J Clin Immunol. 2008;28(2):194\u2013206. https:\/\/doi.org\/10.1007\/s10875-007-9147-2.","journal-title":"J Clin Immunol"},{"key":"900_CR79","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-024-2770-x","author":"J Wang","year":"2024","unstructured":"Wang J, Ye F, Chai H, Jiang Y, Wang T, Ran X, et al. Advances and applications in single-cell and Spatial genomics. Sci China Life Sci. 2024. https:\/\/doi.org\/10.1007\/s11427-024-2770-x.","journal-title":"Sci China Life Sci"},{"issue":"11","key":"900_CR80","doi-asserted-by":"publisher","first-page":"e2305592","DOI":"10.1002\/advs.202305592","volume":"11","author":"M Lyu","year":"2024","unstructured":"Lyu M, Xu G, Zhou J, Reboud J, Wang Y, Lai H, et al. Single-Cell sequencing reveals functional alterations in Tuberculosis. Advanced science (Weinheim. Baden-Wurttemberg Germany). 2024;11(11):e2305592. https:\/\/doi.org\/10.1002\/advs.202305592.","journal-title":"Baden-Wurttemberg Germany)"},{"issue":"13","key":"900_CR81","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1016\/j.celrep.2019.05.045","volume":"27","author":"A Lepletier","year":"2019","unstructured":"Lepletier A, Hun ML, Hammett MV, Wong K, Naeem H, Hedger M, et al. Interplay between Follistatin, activin A, and BMP4 signaling regulates postnatal thymic epithelial progenitor cell differentiation during aging. Cell Rep. 2019;27(13):3887\u2013e9014. https:\/\/doi.org\/10.1016\/j.celrep.2019.05.045.","journal-title":"Cell Rep"},{"issue":"4","key":"900_CR82","doi-asserted-by":"publisher","first-page":"e0160021","DOI":"10.1128\/jvi.01600-21","volume":"96","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yan Q, Luo K, He P, Hou R, Zhao X, et al. Analysis of B cell receptor repertoires reveals key signatures of the systemic B cell response after SARS-CoV-2 infection. J Virol. 2022;96(4):e0160021. https:\/\/doi.org\/10.1128\/jvi.01600-21.","journal-title":"J Virol"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00900-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T01:30:02Z","timestamp":1770859802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["900"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00900-8","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Experimentation Ethics Committee of Zhongshan Hospital, Fudan University (Approval No. DSF-2021-072) and conducted in strict accordance with national animal welfare regulations. Human subject-related protocols were reviewed and approved by the Institutional Ethics Committee of Zhongshan Hospital (Approval No. B2022-419), with full compliance to the Declaration of Helsinki and institutional biosafety requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}